Dr. Shahenda El Naggar Attends Training Workshop in Boston, MA in November 2011

Tag Archives: dana farber cancer

In order for CCHE to provide top care, it must recruit top physicians and professions and stay on the cutting edge. In order to do these things, it must have a robust research program. Part of ensuring that CCHE lives up to these standards is educational sponsorship for its distinguished professionals.

Dr. Shahenda ElNaggar, Head of Basic Research at CCHE 57357 paid a visit to Boston, MA, USA in November 2011 to attend a workshop organised by the American Association for Cancer Research (AACR) entitled “Translational Research for Basic Scientists”. The workshop focused on drug development, visits to several departments at Dana-Farber Cancer Institute, and site visits to various clinics around Boston, among other important topics.

Her visit also allowed her to spend a week at Dana-Farber Cancer Institute being trained in neurosphere and slice culture, two techniques needed for valuable research at CCHE. In doing so, Dr. ElNaggar was able to establish collaborative relationships with several skilled oncology professionals from Dana-Farber Cancer Institute. In her free time, Dr. ElNaggar had the chance to visit Boston University’s Egyptian Club, just as they were beginning their BU Challenge fundraising campaign for CCHE.

Her visit was proudly sponsored by ECN as part of our ongoing effort to aid our excellent staff in enhancing their knowledge, thereby improving the quality of treatment at CCHE.

Please visit this page again in the near future as we will be updating it regularly with new information on the impact of this visit and projects associated with it.

For Dana-Farber Cancer Institute’s Blog on this Partnership, click here.

Representatives from Children’s Hospital Boston (BCH), Dana-Farber Cancer Institute (DFCI) and Children’s Cancer Hospital Egypt 57357 (CCHE) met last Friday, September 21st, at the Signing Ceremony for the Dana-Farber/Children’s Hospital Cancer Center and Children’s Cancer Hospital Egypt 57357’s Pediatric Oncology Fellowship. The ceremony was attended by numerous dignitaries from the aforementioned institutions, including the presidents of both BCH and DFCI, as well as Dr. Hany Hussein, the President of the Children’s Cancer Hospital 57357 Foundation (CCHF) and Dr. Sherif Abouelnaga, the VP of Academic Affairs, Research and Outreach at CCHE. Also in attendance were many board members of supporters of the fellowship project, which took over two years of commitment.

BCH, DFCI and CCHE have partnered together to develop this highly-customized joint fellowship program, the first of its kind. The program is designed to teach its fellows the essentials of patient care, performing research in oncology through collaboration with faculty members and mentors while also strengthening the relationship between the American and Egyptian pediatric oncology communities.

The fellowship is designed to improve the pediatric oncology survival rates and outcomes within Egypt, the Middle East and North Africa (MENA), while simultaneously allowing for a mutual exchange of information, knowledge and experience for both doctors from the region and also from the United States. Participating fellows will have the opportunity to transcend geographic and cultural borders in an effort to learn about pediatric oncology treatment in the MENA region as compared with treatment in the United States, therefore improving their practices through exposure to a multitude of cases and situations which may not be present in their home countries.

By providing a sound education for our global physicians, especially those who treat children and diligent search for a cure for cancer, we are indeed creating a solution to a plethora of problems and ultimately saving lives of children who need their expertise. The creation of this fellowship program between the aforementioned, prestigious international medical institutions is a testimony to the power of cooperation which is essential to world peace and harmony between cultures, and proof that, despite politics, shared goals in healthcare for humanity can unite people everywhere.